The new face of bispecific antibodies: targeting cancer and much more-Reference-Cited by-同舟云学术

The new face of bispecific antibodies: targeting cancer and much more

Published:2006-01 Issue:1 Volume:34 Page:1-6
ISSN:0301-472X
Container-title:Experimental Hematology
language:en
Short-container-title:Experimental Hematology

Author:

Lum Lawrence G.,Davol Pamela A.,Lee Randall J.

Publisher

Elsevier BV

Subject

Cancer Research,Cell Biology,Genetics,Hematology,Molecular Biology

Reference70 articles.

1. Signal transduction by receptors with tyrosine kinase activity;Ullrich;Cell,1990

2. The biology of the 17-1A antigen (Ep-CAM);Balzar;J Mol Med,1999

3. In vitro and in vivo stability and anti-tumour efficacy of an anti-EGFR/anti-CD3 F(ab′)2 bispecific monoclonal antibody;Negri;Br J Cancer,1995

4. Inhibition of angiogenesis by the antiepidermal growth factor receptor antibody ImClone C225 in androgen-independent prostate cancer growing orthotopically in nude mice;Karashima;Clin Cancer Res,2002

5. Bispecific antibody targeted T cell therapy of ovarian cancer: clinical results and future directions;Canevari;J Hematother,1995

Cited by 32 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Bioassay Development for Bispecific Antibodies—Challenges and Opportunities;International Journal of Molecular Sciences;2021-05-19

2. Immunotherapies: Exploiting the Immune System for Cancer Treatment;Journal of Immunology Research;2018

3. B7-H3 as a promising target for cytotoxicity T cell in human cancer therapy;Oncotarget;2016-04-18

4. Computationally Designed Bispecific Antibodies using Negative State Repertoires;Structure;2016-04

5. Magnetically Targeted Stem Cell Delivery for Regenerative Medicine;Journal of Functional Biomaterials;2015-06-30